This program will provide an in-depth understanding of USP and its role in advancing public health safety for patients and health care personnel. Presenters will review challenges and risks, as well as provide guidance on how to safely handle HDs as defined by USP General Chapter <800> standards, which become enforceable in December 2019.
Participants who attended the live version of this program at the 2017 National Academy in Atlanta, GA are not eligible to receive contact hours or CRNI® recertification units through this online program.
Attendees will be able to define the value and scope of USP Chapter <800> and obtain a high-level understanding of the practice and quality standards for handling HDs in health care settings that help promote patient and worker safety, and environmental protection. Attendees will also be able to identify additional resources and educational opportunities to further augment their understanding of implementation procedures of USP Chapter <800> in their practice settings.
USP Hazardous Drugs—Handling in Healthcare Settings becomes a federally enforceable standard on December 1, 2019. The purpose of USP is to protect patients, the environment, and health care personnel who handle hazardous drugs (HDs). These drugs include cytotoxic agents and reproductive hazards, as well as a variety of other agents, including some antibiotics, antipsychotics, and hormones.
This session will provide an overview of the hazards and will list strategies you and your employer can incorporate to mitigate the hazards of exposure to these agents. Emphasis will be on containment strategies and work practices you need to use when mixing and administering HDs.
Information about the standards for hazardous drug (HD) safety is essential for all nurses, because HDs are present in nearly every type of health care setting. Infusion nurses play a vital role in increasing safe handling awareness, providing HD education, promoting safe practices for HD handling, and reducing HD exposure. Nurses must take action to assess current practices and implement changes that improve HD safety.
The goal of this session is to provide practical advice and tools nurses need in order to understand the requirements and implications of the USP Chapter standards.
USP requires three effective protection mechanisms for nurses: closed system drug-transfer devices (CSTDs), personal protective equipment (PPE), and administrative controls. It has been established that contamination of hazardous drugs can occur at multiple points during the process of administration. Examples include the use of luer fittings or open-system connections, spiking the bag at the bedside, priming intravenous tubing, connecting and disconnecting tubing and syringes, and leaking. For nurses not already using CSTDs, incorporating these devices into administration will require a significant change in practice.
This session will provide an in-depth analysis of CSTDs, as well as the importance of and use of PPE.
The goal of this session is to provide practical recommendations for achieving compliance with the hazardous drug (HD) standards discussed in the morning presentation.
Using examples and case studies, the speakers will explain how to:
This entire program has been approved for 5 contact hours. Expiration date for receipt of contact hours: November 3, 2020
This entire program has been approved for 10 CRNI® recertification units and meets the INS meeting criteria.
*Note: Participants who attend the live version of this program at the 2017 National Academy in Atlanta, GA are not eligible to receive contact hours or CRNI® recertification units through this online program.
Patricia Kienle is a member of the USP Compounding Expert Committee and the author of Compounding Sterile Preparations: ASHP’s Visual Guide to Chapter <797> and the Chapter <800> Answer Book. She has cowritten the 8th edition of Assuring Continuous Compliance with Joint Commission Standards: A Pharmacy Guide. She received a pharmacy degree from the Philadelphia College of Pharmacy and Science and a master's degree in public administration from Marywood University in Scranton, Pennsylvania.
Martha Polovich, PhD, has been an oncology nurse since 1980. She was an oncology clinical nurse specialist between 1987 and 2012. As the Oncology Nursing Society's liaison to the National Institute for Occupational Safety and Health (NIOSH), she served on NIOSH's Hazardous Drug Working Group from 2000 to 2007. She was also a member of the United States Pharmacopeia Convention's expert panel for its new general chapter, <800> Hazardous Drugs – Handling in Healthcare Settings. The editor of several Oncology Nursing Society publications related to chemotherapy, Dr. Polovich is a nurse-researcher with a special interest in occupational hazardous drug exposure in health care.
Seth Eisenberg has practiced in the field of oncology since 1983. His experience includes 31 years in hematopoietic stem cell transplantation. He has published articles on hazardous drug safety, chemotherapy, and biotherapy, as well as three book chapters, including a one for Joint Commission Resources. Seth also has presented at national and international nursing and pharmacy conferences, and has been the principal investigator in two published nursing research studies.